These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18091699)

  • 1. Association between inflammatory markers and the interleukin-6 -174 G/C polymorphism is abolished in peripheral arterial occlusive disease.
    Potaczek DP; Undas A; Nowakowski T; Szczeklik A
    Int Angiol; 2007 Dec; 26(4):318-23. PubMed ID: 18091699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interleukin-1beta C+3953T gene polymorphism and peripheral arterial occlusive disease in Polish population].
    Potaczek DP; Krzanowski M; Sanak M
    Przegl Lek; 2005; 62(9):830-2. PubMed ID: 16541711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension.
    Wong LY; Leung RY; Ong KL; Cheung BM
    J Hum Hypertens; 2007 Nov; 21(11):875-82. PubMed ID: 17508011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia.
    Flex A; Gaetani E; Angelini F; Sabusco A; Chillà C; Straface G; Biscetti F; Pola P; Castellot JJ; Pola R
    J Intern Med; 2007 Jul; 262(1):124-30. PubMed ID: 17598820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease.
    Libra M; Signorelli SS; Bevelacqua Y; Navolanic PM; Bevelacqua V; Polesel J; Talamini R; Stivala F; Mazzarino MC; Malaponte G
    J Clin Pathol; 2006 Feb; 59(2):211-5. PubMed ID: 16443741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.
    Chiappelli M; Tampieri C; Tumini E; Porcellini E; Caldarera CM; Nanni S; Branzi A; Lio D; Caruso M; Hoffmann E; Caruso C; Licastro F
    Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.
    Orbe J; Beloqui O; Rodriguez JA; Belzunce MS; Roncal C; Páramo JA
    Clin Chim Acta; 2006 Jun; 368(1-2):138-43. PubMed ID: 16458279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the interleukin-6 c/g-174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels.
    Margaglione M; Bossone A; Cappucci G; Colaizzo D; Grandone E; Di Minno G
    Haematologica; 2001 Feb; 86(2):199-204. PubMed ID: 11224491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
    Unno N; Sakaguchi T; Nakamura T; Yamamoto N; Sugatani J; Miwa M; Konno H
    J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults.
    Kilpinen S; Hulkkonen J; Wang XY; Hurme M
    Eur Cytokine Netw; 2001 Mar; 12(1):62-8. PubMed ID: 11282548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort.
    Sekuri C; Cam FS; Sagcan A; Ercan E; Tengiz I; Alioglu E; Berdeli A
    Coron Artery Dis; 2007 Aug; 18(5):333-7. PubMed ID: 17627181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease.
    Smith FB; Connor JM; Lee AJ; Cooke A; Lowe GD; Rumley A; Fowkes FG
    Thromb Res; 2003; 112(4):209-16. PubMed ID: 14987913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease.
    Schernthaner GH; Plank C; Minar E; Bieglmayer C; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 May; 36(5):333-9. PubMed ID: 16634837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6-174 G > C polymorphism affects the association between IL-6 plasma levels and insulin resistance in type 2 diabetic patients.
    Testa R; Olivieri F; Bonfigli AR; Sirolla C; Boemi M; Marchegiani F; Marra M; Cenerelli S; Antonicelli R; Dolci A; Paolisso G; Franceschi C
    Diabetes Res Clin Pract; 2006 Mar; 71(3):299-305. PubMed ID: 16140413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of interleukin-6 gene and susceptibility to acute myocardial infarction.
    Vakili H; Ghaderian SM; Akbarzadeh Najar R; Tabatabaei Panah AS; Azargashb E
    Coron Artery Dis; 2011 Aug; 22(5):299-305. PubMed ID: 21512395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease.
    Flex A; Gaetani E; Pola R; Santoliquido A; Aloi F; Papaleo P; Dal Lago A; Pola E; Serricchio M; Tondi P; Pola P
    Eur J Vasc Endovasc Surg; 2002 Sep; 24(3):264-8. PubMed ID: 12217290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.